MoCA Cognition
The Montreal Cognitive Assessment (MoCA) is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA empowers healthcare professionals and researchers to detect cognitive impairment related to conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Lewy Body Dementia, VCI/Stroke, frontotemporal dementia, brain metastasis, ALS, sleep behavior disorder, brain tumors, multiple sclerosis, head trauma, depression, schizophrenia, heart failure, substance abuse, HIV, COVID, and more. MoCA is regularly used by nurses, primary care and specialty physicians, occupational therapists, speech-language pathologists, psychologists, researchers, and other clinicians. It quickly and accurately assesses short-term memory, visuospatial abilities, executive functions, attention, concentration and working memory, language, and orientation to time and place.
Learn more
Neurab
Neurab provides a cognitive rehabilitation application for patients with acquired cognitive impairments: its software consists of targeted exercises to rehabilitate specific deficits, aiming to provide a restorative as well a compensative intervention. Neurab realized a device to substitute printed-paper tools. This enables a remote patient supervision, and patient’s performance monitoring through customizable statistics. Neurab provides a digital product with a service network to manage cognitive rehabilitation of both small and big groups of patients, consisting of an online platform, a tablet and many different exercises whose settings are highly customizable but can be ready to use as well (free sessions), especially addressed to patients in post-acute phase. Neurab’s device is a versatile and trustable tool to rehabilitate from cognitive impairments. It is a great aid for independent patients, as it allows to track performance and progresses.
Learn more
Cognistat Assessment System
Cognistat is the leading cognitive test for assessing the five major cognitive ability areas: language, spatial skills, memory, calculations and reasoning. Cognistat was developed at Stanford University and is standardized for adolescents, adults and seniors (60 – 84). It can be administered by any suitably trained healthcare professional. The Cognistat assessment and screening test has been culturally adapted with clinical validity in many languages by collaborating with important universities, academic institutions and customers worldwide. With over 400 peer-reviewed scientific articles, Cognistat’s use in patients with stroke, dementia, traumatic brain injury, major psychiatric disorders and substance abuse is well documented. The Cognistat Assessment System preserves the strengths of the highly regarded paper and pencil version of Cognistat: Assesses five major areas of cognitive functioning, gives a quick yet comprehensive evaluation, utilizes a screen and metric approach.
Learn more
